文献速递心血管MR

基于心脏磁共振T1长与短T1 mapping评估心肌细胞外容积分数在肥厚型心肌病中的预后价值

Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy.
PubMed 文献 · Eur Radiol · 2021-01-15

本研究纳入263例连续转诊行心脏磁共振的肥厚型心肌病患者,采用电影、延迟钆增强及T1长与短T1 mapping序列,前瞻性随访平均28.3±12.1个月。主要终点事件17例(7.0%),ECV与主要及次要终点独立相关,ECV每增加3%主要终点风险增加1.374倍。

要点

  • 肥厚型心肌病患者中,ECV每增加3%,主要终点事件风险增加1.374倍(p<0.001)。
  • ECV对主要和次要终点事件的预测效力优于LGE,且在LGE亚组中ECV仍具独立预测意义。
  • ECV与LVEF及LVEDVI强相关,可用于评估心肌组织结构和功能。

核心结论

  • 在肥厚型心肌病患者中,ECV是预测不良结局的强影像标志物。

研究设计与样本

  • 本研究为前瞻性队列研究,连续纳入263例转诊行心脏磁共振的肥厚型心肌病患者,所有患者均前瞻性随访。
  • 影像方案包括电影、延迟钆增强及T1长与短T1 mapping序列。
  • 主要终点事件包括心源性死亡、心脏移植、流产性猝死及晕厥后心肺复苏;次要终点事件定义为因心力衰竭非计划再住院。

关键影像表现/征象

  • 发生主要终点事件的患者相比无事件患者,LGE范围更广泛(p<0.001)、ECV显著更高(p<0.001)、原生T1更高(p=0.028)。

诊断标准与关键数值

  • 多变量Cox回归分析显示,ECV与主要终点事件独立相关(p<0.001),与次要终点事件独立相关(p=0.047)。
  • ECV每增加3%,主要终点事件发生风险增加1.374倍(p<0.001)。
  • Kaplan-Meier生存分析显示,ECV升高的肥厚型心肌病患者主要终点事件发生率显著更高(p<0.001),次要终点事件发生率亦显著更高(p=0.009)。

临床应用与阅片要点

  • ECV可作为肥厚型心肌病风险分层的影像指标,其预测效力优于LGE,即使在LGE阳性亚组中ECV仍具独立预测意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the prognostic significance of T1 mapping using T1 long and short in hypertrophic cardiomyopathy (HCM) patients.

METHODS: A total of 263 consecutive patients with HCM referred for cardiovascular magnetic resonance (CMR) imaging were enrolled in this study. The imaging protocol consisted of cine, late gadolinium enhancement (LGE), and T1 mapping with T1 long and short. All patients were followed up prospectively. Outcome events were divided into the primary and secondary endpoint events. Primary endpoint events included cardiac death, heart transplant, aborted sudden death, and cardiopulmonary resuscitation after syncope. The secondary endpoint event was defined as unplanned rehospitalization for heart failure.

RESULT: The average follow-up duration was 28.3 ± 12.1 (range: 1-78) months. In all, 17 patients (7.0%) experienced a primary endpoint including 13 cardiovascular deaths, three aborted sudden deaths, and one resuscitation after syncope, and 34 patients experienced a secondary endpoint. Patients with primary endpoints showed a trend towards more extensive LGE (p < 0.001), significantly higher ECV (p < 0.001), and native T1 (p = 0.028) than those without events. In multivariate Cox regression analysis, ECV was independently associated with primary and secondary endpoints (p < 0.001 and p = 0.047, respectively). For every 3% increase, ECV portended a 1.374-fold increase risk of a primary endpoint occurring (p < 0.001). In the Kaplan-Meier survival analysis, the incidence of primary and secondary endpoint events was significantly higher in HCM with increased ECV (p < 0.001 and p = 0.009, respectively).

CONCLUSION: In patients with HCM, ECV is a strong imaging marker for predicting adverse outcome.

KEY POINTS: • ECV is a potent imaging index which has a strong correlation with LVEF and LVEDVI and can evaluate myocardial tissue structure and function. • ECV and LGE can provide a prognostic value in patients with hypertrophic cardiomyopathy. • ECV has stronger predictive effectiveness than LGE; even in the subgroup with LGE, ECV shows independent predictive significance for adverse events.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Li Y, Liu X, Yang F, et al. Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy. Eur Radiol. 2021. PMID: 33449190. doi:10.1007/s00330-020-07650-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。